Please login to the form below

Not currently logged in
Email:
Password:

Paolo Casati named as general manager of Santen Italy

Has over 30 years of experience in the sector

Eye care specialist Santen Pharma has appointed Paolo Casati as general manager of its Italian subsidiary.

Casati brings 30 years of management and global business leadership experience in the ophthalmic sector to the role.

From 2012 to 2014, he served as head of sales force effectiveness at Alcon, an eye care specialist that develops and manufactures medicines and devices for eye care needs.

Prior to that, Casati held a number of senior leadership positions at the firm in sales and marketing departments.

Commenting on his appointment, he said: “Santen group is successful thanks to its commitment to the protection and improvement of eyesight and the quality of life of patients.

“I am very excited to join the team to establish Santen Italy as one of the major companies of reference for the ophthalmic world in Italy.”

Highlights of Casati's career include the creation of the EMEA training organisation at Alcon that covers all business units, technical, sales, management and marketing skills.

Masamichi Sato, head of Santen European group and president of Santen holdings, added: “Our expansion in Italy is an important step in achieving global presence in Europe. Paolo Casati's appointment will bring leadership that fits very well with the company's ambition and values.”

11th December 2014

From: Sales

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
JPA Health Communications

JPA Health is an award-winning public relations, marketing and advocacy firm known for sharing our clients’ commitment to making people...

Latest intelligence

Five companies 20 for 2020
20 for 2020 – Five pharma companies to watch
As a new decade gets into gear, we take a look at five pharma companies that have a lot riding on 2020...
The growing clinical importance of patient-reported outcomes (PROs)
Traditionally, the success or otherwise of medical treatments has been assessed by mortality or clinical assessments of health. However, patient self-reports of health are increasingly seen as central to the...
Generation Z
The roaring ‘20s and Generation Z
How a new generation will shape pharma comms this decade...

Infographics